Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2026-02-19 @ 11:37 AM
Study NCT ID:
NCT01216657
Status:
TERMINATED
Last Update Posted:
2013-06-04
First Post:
2010-04-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma
Sponsor:
Krankenhaus Nordwest
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
S379 SUMA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None